The effect of sleep medications on prospective and retrospective memory: a population-based study.

Prog Neuropsychopharmacol Biol Psychiatry

Departamento de Psicobiologia, Universidade Federal de São Paulo, Rua Napoleão de Barros, 925, São Paulo, SP 04024-002, Brazil. Electronic address:

Published: January 2021

Sleep medications, especially benzodiazepines, are known to cause motor and cognitive impairments as side-effects from their use. However, an evaluation of the effects of sleep medications in general on prospective and retrospective memory remains to be seen. Thus, the effects of the different types of sleep medicines were assessed using the total score and the 8 subscales of the Prospective and Retrospective Memory Questionnaire (PRMQ) in a representative sample from the Municipality of São Paulo. The effects of each type of medication on these same parameters were evaluated afterwards. Each analysis was performed controlling for different covariates to observe their degree of interference on the observed results. Impairment due to use of sleep aid medication was observed in 6 of the 8 subscales, as well in the overall score of the PRMQ when compared to non-users. Prospective subscales were particularly affected, even when controlling for highly interfering covariates such as depression and anxiety, and objective sleep variables related to sleep architecture and wakefulness in the night. Few effects were detected between the various types of medication even when controlling for covariates, suggesting that a sample with higher power is necessary to conduct a more detailed analysis. Using pharmacological aids to improve sleep may impair prospective and (to some extent) retrospective memory. Therefore, the relationship between sleep impairment, memory deficits and medication use must be considered by physicians.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2020.110043DOI Listing

Publication Analysis

Top Keywords

retrospective memory
16
sleep medications
12
prospective retrospective
12
sleep
9
controlling covariates
8
prospective
5
memory
5
medications prospective
4
retrospective
4
memory population-based
4

Similar Publications

Background: Prospective memory (PM), the ability to execute an intended action in the future (e.g., taking medications), is impaired in Alzheimer's disease (AD).

View Article and Find Full Text PDF

Background: Multispecialty Interprofessional Team (MINT) Memory Clinics manage dementia care in primary care, allowing for more efficient use of limited specialist resources. This study examined the characteristics of patients on their initial assessment in the MINT clinic and investigated the five-year trajectory of patients with mild cognitive impairment (MCI).

Method: We conducted a retrospective chart review of 751 patients assessed within a MINT Memory Clinic between June 2006 and May 2019 to collect data on age, gender, diagnosis, and MoCA scores.

View Article and Find Full Text PDF

Background: Parkinson's Disease (PD) is known to cause cognitive and behavioral problems, especially in executive-attentional areas. For some patients, medication is not effective, and surgery is considered a treatment option. However, changes in mood and cognition have been reported after surgical intervention in the subthalamic nucleus (STN) or the internal globus pallidus (GPi), but the literature is inconsistent.

View Article and Find Full Text PDF

Background: Subjective cognitive decline (SCD) is a preclinical stage of Alzheimer's disease (AD), with correlations to cerebral amyloid and tau and accelerated cognitive decline. Studies have also revealed an association between sleep fragmentation and such AD biomarkers and cognitive decline, suggesting that cognitive function should be monitored in individuals experiencing excessive sleepiness. It is unclear if and how sleep dysfunction relates to SCD apart from AD biomarkers, as well as symptoms related to SCD and sleep dysfunction, such as depression.

View Article and Find Full Text PDF

Background: This study focused on comparing clinical and neuropsychological aspects in individuals with subjective cognitive decline (SCD) versus healthy controls (HCs) in a memory clinic, aiming to identify factors linked to the progression towards mild cognitive impairment (MCI) or dementia.

Method: We retrospectively analysed data from 945 SCD patients and 68 HCs at Clínica Universidad de Navarra memory clinic between 2001 and 2017, with 450 followed up until January 2020, the study involved various assessments including medical interviews, lab tests, neuropsychological evaluations (during the first interview and follow-ups), and brain imaging. All the neuropsychological variables were adjusted for age, sex and education.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!